Argan, Inc. (AGX) Stock Forecast
AGX analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 6 analysts
- Price target
- $570.50 average of analyst targets
- Upside to target
- +65.1% from the latest close
- Next earnings
- December 3, 2026 EPS estimate $3.34
- 52-week range
- $267.62 – $798.55
AGX analyst ratings
6 analystsNumber of analysts at each rating.
AGX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
AGX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Oct '26) | $3.17 | $2.84 | $3.50 | $2.17 | +46.2% | 5 |
| Current fiscal year (FY2027) | $13.27 | $12.51 | $14.33 | $9.74 | +36.2% | 5 |
| Next fiscal year (FY2028) | $16.11 | $12.66 | $19.07 | $13.27 | +21.4% | 5 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
AGX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Oct '26) | $358.8M | $336.0M | $387.0M | +42.9% | 6 |
| Current fiscal year (FY2027) | $1.40B | $1.35B | $1.47B | +48.3% | 6 |
| Next fiscal year (FY2028) | $1.69B | $1.50B | $1.85B | +20.4% | 6 |
AGX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
AGX revenue: reported and forecast
AGX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Oct '26) | $3.02 | $3.02 | $2.97 | $3.15 | $3.17 | +4.9% | 3 up · 1 down |
| Current fiscal year (FY2027) | $12.24 | $12.24 | $12.09 | $13.06 | $13.27 | +8.4% | 3 up · 1 down |
| Next fiscal year (FY2028) | $16.25 | $16.25 | $15.99 | $16.23 | $16.11 | −0.9% | 2 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
AGX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; AGX beat in 11 of 12.
What analysts expect from AGX
6 analysts cover Argan; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $570.50, 65.1% above the latest close of $345.56. Analysts expect earnings of $13.27 per share for FY2027, +36.2% from a year earlier. For FY2028 the average estimate is $16.11 per share on revenue of $1.7 billion. Argan beat the EPS estimate in 11 of the last 12 quarters.
Related: AGX income statement, AGX key metrics, AGX chart. See the AGX stock overview for the latest quote and news.
AGX forecast FAQ
What is Argan's price target?
The average analyst price target for Argan is $570.50, 65.1% above the latest close of $345.56.
Is Argan a buy, hold or sell?
Of 6 analysts covering Argan, 3 rate it a strong buy, 1 a buy, 1 a hold, 1 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Argan's EPS forecast?
Analysts forecast $13.27 per share for FY2027 (range $12.51 to $14.33); for FY2028 the estimate is $16.11.
What is Argan's revenue forecast?
The average revenue estimate for FY2027 is $1.4 billion, growth of 48.3%; for FY2028 it is $1.7 billion.
When does Argan report earnings?
Argan is expected to report results for the quarter ending October 31, 2026 on December 3, 2026 after the market closes; the EPS estimate is $3.34.
Does Argan usually beat earnings estimates?
Argan reported EPS at or above the analyst estimate in 11 of the last 12 quarters.